Postgraduate

Modules

Modules

ONC8027 : Cancer Drug Development and Innovative therapies (E-learning)

Semesters
Semester 1 Credit Value: 10
ECTS Credits: 5.0

Aims

This module looks at how new cancer medicines are developed, marketed and introduced into clinical practice. The wider context of the impact new concepts in personalized health care and new medicine technologies will be evaluated, including CAR-T and novel biological therapies

Outline Of Syllabus

Topics covered:

•       Product Development 1:-Challenges, Barriers and Benefits.
•       Product Development 2: Phase I/II/III/IV trials are they still relevant?
•       Product Development 3 New Models of clinical drug development
•       Innovation 1: Personalized Medicine and Biomarkers
•       Innovation 2: New therapies and Biosimilars
•       Innovation 3: CAR-T and cellular therapies: Part 1
•       Innovation 4: CAR-T and cellular therapies: Part 2
•       Innovation 5: Tumour Agnostic Treatments
•       Marketing and Promotion payer, provider and clinician perspective to prescribers
•       Models of Joint Working between industry and healthcare systems

Teaching Methods

Teaching Activities
Category Activity Number Length Student Hours Comment
Guided Independent StudyAssessment preparation and completion210:0020:00Independent assessment preparation
Guided Independent StudyDirected research and reading123:0036:00Online content
Guided Independent StudyReflective learning activity122:0024:00Reflective Online Journal
Guided Independent StudyIndependent study81:008:00Supplemental reading
Guided Independent StudyOnline Discussion121:0012:00Via online discussion board
Total100:00
Teaching Rationale And Relationship

Through a series of online tutorials and weekly activities as well as private study (including directed reading) students will gain a detailed knowledge of understanding of how cancer medicines reach patients in the ‘real world’, gain insight into the development and use of innovative technologies and understand challenges faced by health systems in introducing these medicines.

Students are encouraged to participate in online collaborative discussions via the discussion boards so they can help debate current practices and the reflective journal will help to consolidate their understanding of the curriculum.

Student's responses to the activities will be posted on the discussion board on blackboard (used for online discussion) to foster dialogue between students and the instructors. The instructors will monitor and comment on all student responses to the activities to help with the consolidation of
knowledge and understanding of the learning outcomes.

Assessment Methods

The format of resits will be determined by the Board of Examiners

Other Assessment
Description Semester When Set Percentage Comment
Essay1M90One essay question (2000 words).
Portfolio1M10Participation in collaborative e-learning activities throughout the module.
Formative Assessments
Description Semester When Set Comment
Written Examination1MNew technology implementation Exercise
Assessment Rationale And Relationship

This assessment strategy is designed to allow the students' to demonstrate a depth of knowledge in a focused topic of a non-prescriptive aspect of cancer management.

The short essay question is designed to assess the students' knowledge and understanding across the breadth of all topics covered in the module.

A participation grade is included to encourage and reward the student's engagement with the
collaborative activities.

Should a student fail the participation assessment and have to undertake a re-sit they will have to complete a different form of assessment. The student will be asked to look at 2 participation activities as identified by the module leader/team and submit a 500 word written summary (approx. 250 words per activity).

Reading Lists

Timetable